Show simple item record

Authordc.contributor.authorMaccioni Baraona, Ricardo es_CL
Authordc.contributor.authorRojo, Leonel es_CL
Authordc.contributor.authorFernández, Jorge A. 
Authordc.contributor.authorKuljis, Rodrigo O. es_CL
Admission datedc.date.accessioned2011-04-06T10:50:24Z
Available datedc.date.available2011-04-06T10:50:24Z
Publication datedc.date.issued2009
Cita de ítemdc.identifier.citationNEUROIMMUNOMODULATION: FROM FUNDAMENTAL BIOLOGY TO THERAPY Book Series: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Volume: 1153, Pages: 240-246, 2009en_US
Identifierdc.identifier.issn0077-8923
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/119148
Abstractdc.description.abstractThe idea that alterations in the brain immunomodulation are critical for Alzheimer’s disease (AD) pathogenesis provides the most integrative view on this cognitive disorder, considering that converging research lines have revealed the involvement of inflammatory processes in AD. We have proposed the damage signal hypothesis as a unifying scheme in that release of endogenous damage/alarm signals, in response to accumulated cell distress (dyslipidemia, vascular insults, head injury, oxidative stress, iron overload, folate deficiency), is the earliest triggering event in AD, leading to activation of innate immunity and the inflammatory cascade. Inflammatory cytokines play a dual role, either promoting neurodegeneration or neuroprotection. This equilibrium is shifted toward the neurodegenerative phenotype upon the action of several risk factors that trigger innate damage signals that activatemicroglia and the release of tumor necrosis factor-α, interleukin-6, and some trophic factors. In this neuroimmunomodulatory hypothesis we integrate different risk factors withmicroaglial activation and the resulting neuronal alterations and hyperphosphorylations of tau protein. The progression of AD, with slowly increasing damage in brain parenchyma preceding the onset of symptoms, suggests that tissue distress triggering damage signals drives neuroinflammation. These signals via toll-like receptors, receptors for highly glycosylated end products, or other glial receptors activate sensors of the native immune system, inducing the anomalous release of cytokines and promoting the neurodegenerative cascade, a hallmark of brain damage that correlates with cognitive decline.en_US
Patrocinadordc.description.sponsorshipThis research has been supported by grants from the Fondo Nacional de Desarrollo Científico y Tecnológico (1080254), the International Center for Biomedicine (ICC), and Neuroinnovation Ltd.en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherBLACKWELLen_US
Keywordsdc.subjectAlzheimer’s diseaseen_US
Títulodc.titleThe Role of Neuroimmunomodulation in Alzheimer's Diseaseen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record